Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCb vs EC-T as Adjuvant Chemotherapy in ER+/HER2- Breast Cancer
NCT05901428Phase 3Recruiting
- Sponsor
- Fudan University
- Start
- Jun 2023
- Primary completion
- Jun 2029
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin in breast cancer, sponsored by Fudan University. Started Jun 2023; status: recruiting.
02
Drugs
carboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05901428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05901428.